Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
INTRODUCTION: Central venous catheters (CVCs) are utilized as access for hemodialysis (HD) in emergency settings in Baguio General Hospital and Medical Center (BGHMC). CVCs remain the primary vascular access for chronic kidney disease (CKD) patients undergoing hemodialysis until there is available chronic HD access. Among nosocomial infections, 10-15% are intravascular device-related bacteremia, in which CVCs account for most of these infections, with an estimated mortality rate of 12-25% (9). There is a discernible scarcity of local publications explicitly addressing catheter-related bloodstream infections (CRBSI) in hemodialysis patients (15).
METHODS: Cross-sectional study and random sampling were performed by reviewing medical charts, hemodialysis unit data, and microbiological laboratory records. The study population included adult patients diagnosed with CKD requiring HD, who had been inserted with CVC and underwent hemodialysis in BGHMC. A sample size of at least 329 subjects was needed to achieve 95% significance level using OpenEpi and was modified based on an expected occurrence rate of 31% for CRBSI in hemodialysis patients (15).
RESULTS: Prevalence of CRBSI was documented at 12.67 episodes per 1000 CVC days with median duration of CVC at 58 days. Pseudomonas aeruginosa (n = 6, 15%) was the most common causative organism for gram negative and Staphylococcus aureus (n = 5, 12.5%) for gram positive isolates.
CONCLUSION: The noted increased prevalence of CRBSI could be attributed to prolonged catheter days. The increasing prevalence calls for re-evaluation of practices involving CVC and strict adherence to recommendation that CVC should be switched as soon as possible from CVC to arteriovenous fistula (AVF) or arteriovenous graft (AVG).
